Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J.M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Judith A. Burger, Meliawati Poniman, Melissa Oomen, Dirk Eggink, Tom P.L. Bijl, Hugo D.G. van Willigen, Elke Wynberg, Bas J. Verkaik, Orlane J.A. Figaroa, Peter J. de Vries, Tessel M. Boertien, Roger Le Grand, Menno D. de Jong, Maria Prins, Amy W. Chung, Godelieve J. de Bree, Rogier W. Sanders, Marit J. van Gils
doi: https://doi.org/10.1101/2021.05.26.21256092
Marloes Grobben
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Karlijn van der Straten
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
2Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Philip J.M. Brouwer
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Mitch Brinkkemper
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Pauline Maisonnasse
3Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, 92265 Fontenay-aux-Roses, France
Nathalie Dereuddre-Bosquet
3Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, 92265 Fontenay-aux-Roses, France
Judith A. Burger
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Meliawati Poniman
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Melissa Oomen
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Dirk Eggink
4National Institute for Public Health and the Environment, RIVM, 3721 MA Bilthoven, The Netherlands
Tom P.L. Bijl
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Hugo D.G. van Willigen
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Elke Wynberg
5Department of Infectious Diseases, Public Health Service of Amsterdam, GGD, 1018 WT Amsterdam, The Netherlands
Bas J. Verkaik
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Orlane J.A. Figaroa
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Peter J. de Vries
6Department of Internal Medicine, Tergooi Hospital, 1213 XZ Hilversum, The Netherlands
Tessel M. Boertien
6Department of Internal Medicine, Tergooi Hospital, 1213 XZ Hilversum, The Netherlands
Roger Le Grand
3Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, INSERM, CEA, 92265 Fontenay-aux-Roses, France
Menno D. de Jong
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Maria Prins
2Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
5Department of Infectious Diseases, Public Health Service of Amsterdam, GGD, 1018 WT Amsterdam, The Netherlands
Amy W. Chung
7Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Victoria 3000, Australia
Godelieve J. de Bree
2Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
Rogier W. Sanders
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
8Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA
Marit J. van Gils
1Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, 1105 AZ Amsterdam, The Netherlands
- Supplementary Materials[supplements/256092_file03.pdf]
Posted June 02, 2021.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J.M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Judith A. Burger, Meliawati Poniman, Melissa Oomen, Dirk Eggink, Tom P.L. Bijl, Hugo D.G. van Willigen, Elke Wynberg, Bas J. Verkaik, Orlane J.A. Figaroa, Peter J. de Vries, Tessel M. Boertien, Roger Le Grand, Menno D. de Jong, Maria Prins, Amy W. Chung, Godelieve J. de Bree, Rogier W. Sanders, Marit J. van Gils
medRxiv 2021.05.26.21256092; doi: https://doi.org/10.1101/2021.05.26.21256092
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Marloes Grobben, Karlijn van der Straten, Philip J.M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Judith A. Burger, Meliawati Poniman, Melissa Oomen, Dirk Eggink, Tom P.L. Bijl, Hugo D.G. van Willigen, Elke Wynberg, Bas J. Verkaik, Orlane J.A. Figaroa, Peter J. de Vries, Tessel M. Boertien, Roger Le Grand, Menno D. de Jong, Maria Prins, Amy W. Chung, Godelieve J. de Bree, Rogier W. Sanders, Marit J. van Gils
medRxiv 2021.05.26.21256092; doi: https://doi.org/10.1101/2021.05.26.21256092
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3041)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12962)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4772)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3028)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2364)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1231)
- Primary Care Research (515)
- Public and Global Health (7135)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (504)
- Toxicology (63)
- Transplantation (218)
- Urology (187)